Literature DB >> 7804665

A controlled psychiatric study of individuals at risk for Huntington's disease.

R S Shiwach1, C G Norbury.   

Abstract

BACKGROUND: The study tested specific hypotheses that (a) there is an increased incidence of psychiatric disorders in asymptomatic heterozygotes for Huntington's disease (HD) compared with the normal homozygotes, and (b) there is an increased incidence of psychiatric disorders in the adult offspring of Huntington's disease patients compared with their partners.
METHOD: A controlled study was made of 93 apparently healthy individuals (at 50% risk), who had given DNA samples for the predictive test, and 70 of their partners. Current and past psychopathology was assessed and compared with the DNA predictive test results based on linkage analyses. The results of psychiatric assessments of the two groups were compared.
RESULTS: DNA test results were available for 53 subjects (of 93). Five subjects at risk for HD were omitted from the study. The asymptomatic heterozygotes (n = 20) showed no significant increase in the incidence of any psychiatric episode, depression, schizophrenia or behavioural disorder when compared with the normal homozygotes (n = 33). The whole tested group showed a significantly greater number of psychiatric episodes than their partners (n = 43).
CONCLUSIONS: Asymptomatic HD gene carriers do not have a greater incidence of psychiatric disorders than the non-gene carriers born to a HD parent.

Entities:  

Mesh:

Year:  1994        PMID: 7804665     DOI: 10.1192/bjp.165.4.500

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  9 in total

1.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

2.  Modified electroconvulsive therapy for the treatment of refractory schizophrenia-like psychosis associated with Huntington's disease.

Authors:  Takeshi Nakano; Shinji Ono; Junji Yamaguchi; Ryu Sugimoto; Naohiro Yamaguchi; Yoshiro Morimoto; Tatsuya Kubo; Hiroki Ozawa; Naohiro Kurotaki
Journal:  J Neurol       Date:  2012-10-25       Impact factor: 4.849

3.  Psychiatric disorders in preclinical Huntington's disease.

Authors:  Camille L Julien; Jennifer C Thompson; Sue Wild; Pamela Yardumian; Julie S Snowden; Gwen Turner; David Craufurd
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

4.  Huntington's Disease and Striatal Signaling.

Authors:  Emmanuel Roze; Emma Cahill; Elodie Martin; Cecilia Bonnet; Peter Vanhoutte; Sandrine Betuing; Jocelyne Caboche
Journal:  Front Neuroanat       Date:  2011-08-23       Impact factor: 3.856

5.  Multiple pathways contribute to the pathogenesis of Huntington disease.

Authors:  Shihua Li; Xiao-Jiang Li
Journal:  Mol Neurodegener       Date:  2006-12-16       Impact factor: 14.195

Review 6.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

7.  A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington's Disease Gene Mutation.

Authors:  Xin Du; Terence Y C Pang; Anthony J Hannan
Journal:  Front Neurol       Date:  2013-07-09       Impact factor: 4.003

Review 8.  3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future.

Authors:  Isaac Túnez; Inmaculada Tasset; Verónica Pérez-De La Cruz; Abel Santamaría
Journal:  Molecules       Date:  2010-02-10       Impact factor: 4.411

9.  Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree.

Authors:  Bernardo Barahona Corrêa; Miguel Xavier; João Guimarães
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-02-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.